Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
Abstract Background Alpha-1-antitrypsin deficiency (AATD) is a rare inherited condition caused by mutations of the SERPINA1 gene that is associated with the development of a COPD like lung disease. The comorbidities in patients with AATD-related lung diseases are not well defined. The aim of this st...
Main Authors: | Sebastian Fähndrich, Frank Biertz, Annika Karch, Björn Kleibrink, Armin Koch, Helmut Teschler, Tobias Welte, Hans-Ulrich Kauczor, Sabina Janciauskiene, Rudolf A. Jörres, Timm Greulich, Claus F. Vogelmeier, Robert Bals, on behalf of the COSYCONET investigators |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-09-01
|
Series: | Respiratory Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12931-017-0655-1 |
Similar Items
-
Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry
by: Bernhard N, et al.
Published: (2017-05-01) -
The patient profile of individuals with Alpha-1 antitrypsine gene mutations at a referral center in Brazil
by: Manuela Brisot Felisbino, et al. -
Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients
by: Florian M. Karl, et al.
Published: (2017-04-01) -
Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01) -
Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)